Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Alexander (Ali) Beiner (UK).

TOPIC: Can Psychedelics Change Society?

We all know psychedelics can change your mind, but can they change society? This is the question at the heart of Alexander Beiner's new book 'The Bigger Picture: How psychedelics can help us make sense of the world', and in this talk he'll draw on cutting-edge research in neuroscience, systems change, sociology and psychology to reveal how psychedelic experiences can help us navigate the complex world we live in.

You'll learn:

How psychedelic experiences can help us make sense of AI and the internet in new ways
What the cognitive science of psychedelic experiences tells us about solving complex problems
The dark side of the psychedelic renaissance, and how to grapple with it
Where psychedelic science intersects with systems change, and why it matters
How psychedelic experiences can fundamentally change our view on reality, and one another

EVENT DETAILS

DATE: Tuesday 10th October 2023
TIME: 6:55pm (AEDT) for 7:00pm start, finishing at 8:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTER

Alexander (Ali) Beiner (UK)
Author and Journalist

Alexander Beiner is an author and journalist. His book 'The Bigger Picture: How psychedelics can help us make sense of the world' has been hailed as 'the most important book on psychedelics to come about in a long while' (David Jay Brown), which "presents a compelling and nuanced argument as to why psychedelic science could change the world for the better." (Prof. Robin Carhart-Harris). He's an executive director of Breaking Convention, a UK charity which hosts one of the world's largest conferences on psychedelic science and culture. He also runs a popular Substack, The Bigger Picture, where he writes about popular culture, AI, psychedelics and systems change. You can read more about his work here.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.